Intravenous Immunoglobulin (IVIG)
JJ · Effective Oct 1, 2015
31 active Medicare policies list D84.9, and 4 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Apr 17, 2022
JE · Effective Apr 17, 2022
JF · Effective Apr 17, 2022
4 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D84.9 |
|---|---|---|
| Flow Cytometry, Ektacytometry, DNA Ploidy, and S-phase Fraction | Jun 5, 2023 | Covered |
| Plerixafor | Jan 9, 2024 | Covered |
| Policy | Effective | Status of D84.9 |
|---|---|---|
| Polymerase Chain Reaction Respiratory Viral Panel Testing | Not recorded | Covered |
| Policy | Effective | Status of D84.9 |
|---|---|---|
| Respiratory Viral Panel Testing in the Outpatient Setting |
JJ · Effective Apr 17, 2022
JM · Effective Apr 17, 2022
J5 · Effective Apr 17, 2022
J8 · Effective Apr 17, 2022
J6 · Effective Aug 1, 2022
JK · Effective Aug 1, 2022
J6 · Effective Jul 13, 2025
JK · Effective Jul 13, 2025
J9 · Effective Dec 12, 2021
JH · Effective Dec 12, 2021
JL · Effective Dec 12, 2021
National · Effective Jul 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Aug 6, 2026
National · Effective Aug 6, 2026
National · Effective May 14, 2026
J5 · Effective Aug 6, 2026
J6 · Effective Apr 1, 2026
J6 · Effective Apr 1, 2026
JL · Effective Sep 10, 2026
J9 · Effective Sep 10, 2026
| Oct 1, 2026 |
| Covered |